Top

FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

Awarded

FDABAA-25-00123_AwardFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → FDA Office Of Acquisitions And Grants ServicesView Agency

Contract Value

$16,737,952.78

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Awardee

Please_see_SpreadsheetView Profile

Award Issued Date

09/30/2025, 12:00:00 AM UTC

Documents

(2)

AwardsFY25Data.pdf

PDF

BAATrackingSheet_AwardsFY25Data-11-20-25.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseAwarded

PostedNov 24

Award Notice

AwardedSep 30

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA Office Of Acquisitions And Grants Services

Contacts1 person available

OfficeRockville, MD, 20857, USA

Organization / Agency

Department Of Health And Human Services → FDA Office Of Acquisitions And Grants Services

View Agency Profile

Office AddressRockville, MD, 20857, USA

Contacts

Ian Weiss

contact@example.gov

+1 (555) 000-0000

Full Description

Amendment 02 - updated Spreadsheet to include an additional Award

Amendment 01- updated Spreadsheet to include an additional Award

Please see attached Spreadsheet for all contracts awarded in this oppertunity. A total of 15 Contracts were awarded in FY25 from this BAA Announcement.

Similar Contracts

Same NAICS industry code

NAICS: 541714

New

Federal

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Solicitation # W911SR-26-R-HEAL

The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.

POSTED

DEADLINE

Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells

Solicitation # NIH-NOI-PCA-NIA-01590

The National Institute on Aging (NIA), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for the validation and optimization of ONE-STEP tagging in human induced pluripotent stem cells (iPSCs). This acquisition aims to support the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer’s Disease and Related Dementias (CARD) by generating functionally engineered iPSC lines for research into Alzheimer’s disease and related dementias. The project involves high-activity guide identification, Bxb1 mRNA and cargo plasmid delivery optimization, and the generation of ADRD variant, MAPT 4R, and wild-type process-control clones. All deliverables must be repository-ready, meeting strict quality control standards including long-read sequencing, karyotype analysis, and SNP arrays to ensure scientific continuity and data integrity. The government intends to award this contract to The Jackson Laboratory, citing them as the only responsible source capable of meeting the requirements under FAR 6.302-1 and FAR 13.501(a). This determination is based on the laboratory's unique continuity with the existing iNDI program, established workflows for specific background lines, and proven success in large-scale CRISPR/Cas9 engineering. The total estimated contract value is 3,353,115.00 dollars, covering a base year from September 1, 2026, to August 31, 2027, and an option year extending to August 31, 2028. While this is a sole-source intent, the government will consider capability statements from other sources submitted by August 21, 2026, to determine if adequate competition exists.

National Institutes Of Health Olao

POSTED

DEADLINE

Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70

Solicitation # 75N98026Q00996

The National Cancer Institute intends to award a sole-source, firm fixed price contract under solicitation RFQ 75N98026Q00996 to the Viral Vector Core at the Pandemic Institute, University of Oxford. The project involves the design and production of ChAdOx-1 and MVA viral vectors expressing mouse gp70 and the mouse class II major histocompatibility complex invariant chain. This research is critical for evaluating vaccine efficacy against breast cancer brain metastasis, utilizing proprietary chimpanzee adenovirus technology to avoid pre-existing human adenovirus immunity. The contract falls under NAICS code 541714 for biotechnology research and development and has a performance period of six months from the date of award. Payment terms are set at net 30 days following the acceptance of deliverables. While intended as a sole-source procurement due to the proprietary nature of the technology, the agency will consider capability statements from other interested parties submitted by August 24, 2026.

POSTED

DEADLINE

Core Research in Biological Sciences (BIO Core)

Solicitation # 26-517

The National Science Foundation's Directorate for Biological Sciences is offering funding through the Core Research in Biological Sciences solicitation 26-517. This opportunity supports foundational and interdisciplinary research across all biological levels, from molecular to biome scales, encompassing both legacy program topics and new areas of biological science. The program provides single- and multi-investigator awards with flexible budgets and durations to accommodate both small exploratory projects and long-term research commitments. These federal awards are subject to the availability of funds and are managed by the National Science Foundation.

National Science Foundation

POSTED

DEADLINE

On-Site Installation and Training ServicesThis subcontract opportunity with the Department of Commerce NIST involves on-site installation, calibration, and training services located in Gaithersburg, Maryland. The scope of work includes system setup and the verification of technical specifications. While these specific services are not mandatory, they will be given additional evaluation consideration if included in the proposal. The project is designated as a total Small Business Set Aside under NAICS code 541714. Interested parties must submit their responses by August 28, 2026, at 1:00 PM. The solicitation was officially posted on August 15, 2026.

Department Of Commerce Nist

POSTED

DEADLINE

Q301--Zymo Epigenome Sequencing Services

Solicitation # 36C24126Q0748

The Department of Veterans Affairs, specifically the VA Bedford Healthcare System, intends to award a sole source, firm-fixed-price contract to Zymo Research Corporation for Reduced Representation Bisulfite Sequencing services. This project involves DNA methylation profiling of 269 post-mortem human choroid plexus tissue samples, encompassing sample handling, quality control, bisulfite conversion, library preparation, sequencing, and data alignment. The scope of work includes generating approximately 30 million read pairs per sample and producing genome browser tracks. This procurement is conducted as a sole source under authority RFO 6.103-1 because Zymo Research Corporation previously generated a prefrontal cortex dataset for the same study. Utilizing the same vendor is critical to avoid technical confounds that would compromise the scientific validity of the cross-tissue comparison. The requirement falls under NAICS code 541714 and PSC Q301. Interested parties must submit responses by August 21, 2026, at 11:00am EST.

241-NETWORK Contract Office 01 (36C241)

POSTED

DEADLINE

Technical Readiness & Prototype DemonstrationThe Technical Readiness and Prototype Demonstration is a subcontract opportunity issued by the Department of Defense under the FA2553 Oprn Testing and Trg Infr Otti Pk agency. The primary objective of this effort is to demonstrate the technical capability to build, test, and deploy software from commercial facilities into government cloud enclaves, ensuring a secure and automated delivery process. This project falls under NAICS code 541714 and will be performed in Colorado Springs. Interested parties must submit their responses by September 4, 2026, following the posting date of August 13, 2026.

FA2553 Oprn Testing & Trg Infr Otti Pk

POSTED

DEADLINE

Established Clinician Investigator Award to Support Mentoring (KS1)The Established Clinician Investigator Award to Support Mentoring (KS1) is a forecast opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This award is designed to provide established clinician investigators with a sustained period of protected time, enabling them to deliver high-quality mentoring and guidance to early-career clinician research scientists. The program is managed by the Division of Biomedical Research Workforce, which serves as the primary point of contact for interested parties. While specific performance locations and set-aside details are not listed, the award aims to strengthen the pipeline of clinician researchers through structured mentorship support.

National Institutes Of Health

POSTED

DEADLINE

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The National Institute on Aging is issuing a forecast for the Alzheimer's Drug-Development Program to support the pre-clinical and early-stage clinical Phase I development of novel biologic and small-molecule drug candidates. The program aims to identify treatments that prevent Alzheimer's disease, slow its progression, or address cognitive and behavioral symptoms. Funding is available for academic and biotech researchers to conduct development activities internally or through specialized contract research organizations. The initiative focuses on expanding the portfolio of investigational drug candidates for emerging therapeutic targets and diversifying the therapeutic pipeline to support mono-therapy, combination therapy, and precision medicine approaches. This opportunity will utilize the U01 activity code. While applications are not currently being accepted, this notice serves to allow potential applicants time to establish collaborations and design responsive projects.

National Institutes Of Health

POSTED

DEADLINE

Online BAAS Hospitality Administration Degree Program Development

Solicitation # 754-TXST-2026-RFP-507-VPGOI

Texas State University is seeking a partner to develop a competitive and differentiated online Bachelor of Applied Arts and Science degree program in Hospitality Administration. The primary objective is to establish a high-quality academic offering where the total credit requirements are determined by the necessary standards to ensure the program remains distinct and competitive within the hospitality education market. This solicitation, identified by number 754-TXST-2026-RFP-507-VPGOI, was posted on August 12, 2026, with a response deadline of September 18, 2026. The project is managed by Texas State University in Texas, with Dan Alden serving as the primary point of contact for interested parties.

Texas State University

POSTED

DEADLINE

Artificial Intelligence (AI) System Integration and GovernanceThis subcontract, titled Artificial Intelligence (AI) System Integration and Governance, is issued by the Texas Health and Human Services Commission. The project focuses on the integration of AI tools designed for administrative automation and case analysis. All implementations are strictly subject to ethical governance standards and require prior written approval from the Department of Family and Protective Services. The opportunity was posted on August 12, 2026, with a response deadline of September 3, 2026. It is categorized under NAICS code 541714, reflecting a focus on customized computer programming services. Interested parties can find further details through the Texas SmartBuy portal.

Health and Human Services Commission

POSTED

DEADLINE

FDA-Cleared AI-Based Contouring IntegrationThe Department of Veterans Affairs, through Network Contract Office 16, is seeking a subcontract for the integration of AutoContour, an FDA-cleared AI system. This technology is designed to provide automated anatomical structure delineation to enhance radiation oncology treatment planning. The project will be performed in Jackson, Mississippi, under NAICS code 541714. Interested parties must submit their responses by August 21, 2026, at 3:00 PM. The solicitation was officially posted on August 12, 2026, and focuses on implementing advanced artificial intelligence to streamline clinical workflows within the VA healthcare system.

256-NETWORK Contract Office 16 (36C256)

POSTED

7 days ago

DEADLINE

in 2 days

View Details

More opportunities from Department Of Health And Human Services → FDA Office Of Acquisitions And Grants Services

Same awarding agency

NAICS: 541990

Federal

Regulatory Decision Frameworks and Predictive ModelingThe contract involves the development of AI and machine learning-driven predictive models and decision support tools aimed at enhancing regulatory decision-making processes. Leveraging both high-quality scientific data and real-world data, the objective is to improve the accuracy and efficiency of regulatory evaluations. This initiative is critical for advancing the FDA's ability to assess and manage health-related risks more effectively. This subcontract falls under the NAICS code 541990 and is managed by the FDA Office of Acquisitions and Grants Services within the Department of Health and Human Services. The work will be performed in Silver Spring, Maryland, and focuses on creating frameworks that support regulatory decisions through sophisticated data analysis and predictive modeling techniques. The contract was posted in January 2026 and seeks specialized expertise to integrate innovative technologies into regulatory workflows.

All Other Professional, Scientific, and Technical Services

POSTED

DEADLINE

Clinical and Surrogate Endpoint Development for Regulatory ApprovalThis contract involves conducting research aimed at defining and validating clinical or surrogate endpoints to support regulatory submissions, with a particular focus on facilitating accelerated approval pathways. The work is designed to provide critical data that aids in meeting regulatory requirements, helping to streamline the approval process for new therapies or medical products. The subcontract, issued by the FDA Office of Acquisitions and Grants Services under the Department of Health and Human Services, falls under the NAICS code 541715, which typically includes research and development in the physical, engineering, and life sciences. The place of performance is located in Silver Spring, with the contract posted for potential subcontracting opportunities on January 13, 2026. The emphasis on endpoint development highlights the importance of scientific validation in advancing medical innovation through regulatory channels.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Patient Preference Information (PPI) Quantification StudiesThis contract involves designing and conducting studies to measure patient preferences in clinical decision-making, with a particular focus on rare diseases. The work will employ structured survey techniques alongside statistical methodologies to quantitatively assess how patients weigh different treatment options and outcomes, providing valuable insights to inform regulatory and healthcare decisions. The contract is a subcontract managed by the FDA Office of Acquisitions and Grants Services under the Department of Health and Human Services, with the place of performance in Silver Spring, Maryland. The effort falls under the NAICS code 541611, which pertains to administrative management and general management consulting services. The project aims to enhance understanding of patient perspectives to support more patient-centered healthcare and regulatory processes.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Digital Health Integration and Real-World Evidence (RWE) AnalyticsThe contract focuses on the development and validation of digital health tools along with the integration of real-world data into regulatory frameworks. This involves utilizing predictive modeling and data science techniques to enhance the analysis and application of real-world evidence in healthcare settings. The work aims to support regulatory decision-making by leveraging advanced analytics to better interpret and utilize data collected outside traditional clinical trials. Awarded by the FDA Office of Acquisitions and Grants Services under the Department of Health and Human Services, the subcontract is classified under the NAICS code 541715, which pertains to research and development in physical, engineering, and life sciences. The place of performance is located in Silver Spring, and the contract was posted in January 2026. This initiative underscores the agency’s commitment to harnessing innovative digital technologies and data-driven methodologies to improve public health outcomes through more effective regulatory science.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Botanical Drug Safety and Quality EvaluationThe contract involves conducting comprehensive analytical and preclinical studies to evaluate the safety, composition, and quality control of botanical drug products. This includes performing toxicology screenings and employing standardization methods to ensure the botanical drugs meet established safety and quality standards. The work is focused on supporting regulatory compliance and scientific validation of these products. Awarded by the FDA Office of Acquisitions and Grants Services under the Department of Health and Human Services, this subcontract falls under the NAICS code 541990, which pertains to specialized scientific services. The principal place of performance is located in Silver Spring, with the contract posted on January 13, 2026. The scope and nature of the contract emphasize the critical role of rigorous quality assessment for botanical drugs, contributing to public health protection and regulatory oversight.

All Other Professional, Scientific, and Technical Services

POSTED

DEADLINE

Regulatory Science Research in Tobacco Product AssessmentThe contract focuses on conducting comprehensive public health research related to tobacco product use, encompassing behavioral studies, clinical observations, and analysis of policy impacts. The research aims to generate evidence that will inform and support regulatory decisions made by the FDA, ensuring that the agency’s regulatory actions are grounded in robust scientific data. It addresses multiple facets of tobacco use and its implications, which is critical for evaluating products under FDA oversight. This subcontract, issued by the FDA Office of Acquisitions and Grants Services within the Department of Health and Human Services, is identified under NAICS code 541990 and will be performed in Silver Spring. The contract prioritizes research activities that contribute to tobacco product assessment through a regulatory science lens, facilitating the FDA’s mission to protect public health. The focus on evidence-driven analysis highlights the importance of integrating behavioral, clinical, and policy-related research elements to comprehensively understand tobacco product impacts.

All Other Professional, Scientific, and Technical Services

POSTED

7 months ago

DEADLINE

N/A

View Details